NTT DATA Named a Leader in IDC MarketScape for Worldwide Life Science R&D ITO Services 2024

January 21, 2025

NTT DATA Group Corporation

TOKYO - January 21, 2024 - NTT DATA, a global digital business and IT services leader, today announced that it has been named a Leader in the IDC MarketScape: Worldwide Life Science R&D ITO Services 2024 Vendor Assessment (doc # US52703324, November 2024).

According to the report, "NTT DATA's strengths include the company's wide digital transformation capabilities, the scale and adaptability of its wide portfolio of IT delivery capabilities, its partnership ecosystem, and its co-innovation strategy. Its key differentiators include its focus on innovation and investment in R&D, global coverage, and project execution capabilities."

The report went on to note, "Some of its key initiatives are its life science COE, expansion into real-world evidence (RWE)-based R&D analytics, and digital twins for biopharma manufacturing process. It is continuing to invest in its ServiceNow-based pharmacovigilance and medical devices complaints management platform."

"As the life sciences industry continues to rapidly accelerate its digital transformation journey, it looks to experienced partners like NTT DATA that bring to the table robust digital engineering capabilities, niche AI-enabled digital platforms, and a growing focus on real-world data to accelerate drug development and transform business operations", said Dr. Nimita Limaye, Research VP, Life Sciences R&D Strategy & Technology, IDC.

The report noted, "NTT DATA's key solutions include "HCLS Insights Powered by Nucleus" (NTT DATA's Nucleus Insights platform that helps access, integrate, and analyze clinical trial data), its Evidence platform for life science, its GenAI-enabled enterprise medical device management platform, and its "Intelligent Automation for R&D" (a range of intelligent AI-enabled automation services for the connected lab ecosystem of the future)."

NTT DATA served the life sciences industry for over 26 years, continually strengthening and expanding our service offerings through strategic acquisitions and investments. NTT DATA offers a comprehensive suite of patient-centric, digital-first services for life sciences companies. "Our commitment to integrating AI and GenAI across the entire R&D value chain, along with leveraging real-world data, cloud-enabled platforms, and expert data scientists, will drive ongoing innovation in personalized therapies and clinical research. Our global GenAI training program is just one example of how we're helping our staff effectively deliver these solutions, pushing the boundaries of what's possible to improve outcomes for patients and healthcare providers worldwide." said Rob Shaw, Head of Life Sciences of America, NTT DATA.

For more information, please visit NTT DATA's Life Sciences page.